This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (60)  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in JAMA  Topic Collections  • Tobacco  • Alert me on articles by topic  Social Bookmarking   What's this?

Steven A. Schroeder, MD

JAMA. 2005;294:482-487.

Despite the reality that smoking remains the most important preventable cause of death and disability, most clinicians underperform in helping smokers quit. Of the 46 million current smokers in the United States, 70% say they would like to quit, but only a small fraction are able to do so on their own because nicotine is so highly addictive. One third to one half of all smokers die prematurely. Reasons clinicians avoid helping smokers quit include time constraints, lack of expertise, lack of financial incentives, respect for a smoker’s privacy, fear that a negative message might lose customers, pessimism because most smokers are unable to quit, stigma, and clinicians being smokers. The gold standard for cessation treatment is the 5 As (ask, advise, assess, assist, and arrange). Yet, only a minority of physicians know about these, and fewer put them to use. Acceptable shortcuts are asking, advising, and referring to a telephone "quit line" or an internal referral system. Successful treatment combines counseling with pharmacotherapy (nicotine replacement therapy with or without psychotropic medication such as bupropion). Nicotine replacement therapy comes in long-acting (patch) or short-acting (gum, lozenge, nasal spray, or inhaler) forms. Ways to counter clinicians’ pessimism about cessation include the knowledge that most smokers require multiple quit attempts before they succeed, that rigorous studies show long-term quit rates of 14% to 20%, with 1 report as high as 35%, that cessation rates for users of telephone quit lines and integrated health care systems are comparable with those of individual clinicians, and that no other clinical intervention can offer such a large potential benefit.

Author Affiliation: Department of Medicine and Smoking Cessation Leadership Center, University of California, San Francisco.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTERS

Smoking Cessation
Jeffrey L. Kaufman
JAMA. 2005;294(19):2434.
EXTRACT | FULL TEXT  

Smoking Cessation
Frances R. Frankenburg
JAMA. 2005;294(19):2434.
EXTRACT | FULL TEXT  

Smoking Cessation—Reply
Steven A. Schroeder
JAMA. 2005;294(19):2435.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An Electronic Health Record-Based Intervention to Improve Tobacco Treatment in Primary Care: A Cluster-Randomized Controlled Trial
Linder et al.
Arch Intern Med 2009;169:781-787.
ABSTRACT | FULL TEXT  

A 51-Year-Old Woman With Bipolar Disorder Who Wants to Quit Smoking
Schroeder
JAMA 2009;301:522-531.
ABSTRACT | FULL TEXT  

Windows of Opportunity for Culture Change Around Tobacco Use in Mental Health Settings
Solway
J Am Psychiatr Nurses Assoc 2009;15:41-49.
ABSTRACT  

A Randomized Trial of a Pay-for-Performance Program Targeting Clinician Referral to a State Tobacco Quitline
An et al.
Arch Intern Med 2008;168:1993-1999.
ABSTRACT | FULL TEXT  

Tobacco marketing awareness on youth smoking susceptibility and perceived prevalence before and after an advertising ban
Moodie et al.
Eur J Public Health 2008;18:484-490.
ABSTRACT | FULL TEXT  

Effects of financing smoking cessation outpatient services in Taiwan
Chang et al.
Tobacco Control 2008;17:183-189.
ABSTRACT | FULL TEXT  

Stranded in the Periphery -- The Increasing Marginalization of Smokers
Schroeder
NEJM 2008;358:2284-2286.
FULL TEXT  

Educational Disparities in Rates of Smoking Among Diabetic Adults: The Translating Research Into Action for Diabetes Study
Karter et al.
Am. J. Public Health 2008;98:365-370.
ABSTRACT | FULL TEXT  

The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline
Hollis et al.
Tobacco Control 2007;16:i53-i59.
ABSTRACT | FULL TEXT  

Tobacco quitlines: looking back and looking ahead
Anderson and Zhu
Tobacco Control 2007;16:i81-i86.
ABSTRACT | FULL TEXT  

Pharmacist-facilitated tobacco-cessation services in an inpatient setting
Leschisin and Martin
Am J Health Syst Pharm 2007;64:2386-2389.
FULL TEXT  

Pharmacologic Therapy: Novel Approaches for Chronic Obstructive Pulmonary Disease
Bailey and Tashkin
Proc Am Thorac Soc 2007;4:543-548.
ABSTRACT | FULL TEXT  

The Treatment of Smoking by US Physicians During Ambulatory Visits: 1994 2003
Thorndike et al.
Am. J. Public Health 2007;97:1878-1883.
ABSTRACT | FULL TEXT  

Healthcare provider smoking cessation advice among US worker groups
Lee et al.
Tobacco Control 2007;16:325-328.
ABSTRACT | FULL TEXT  

We Can Do Better -- Improving the Health of the American People
Schroeder
NEJM 2007;357:1221-1228.
FULL TEXT  

Emerging pharmacotherapies for smoking cessation
Garwood and Potts
Am J Health Syst Pharm 2007;64:1693-1698.
ABSTRACT | FULL TEXT  

Trials that Matter: Varenicline: A Designer Drug to Help Smokers Quit.
Schroeder and Sox
ANN INTERN MED 2006;145:784-785.
FULL TEXT  

Barriers to tobacco cessation.
Cunningham
CMAJ 2006;175:388-388.
FULL TEXT  

Tobacco still is oral health enemy number one
Schroeder
Journal of the American Dental Association 2006;137:144-148.
FULL TEXT  

Smoking Cessation
Kaufman
JAMA 2005;294:2434-2434.
FULL TEXT  

Smoking Cessation--Reply
Schroeder
JAMA 2005;294:2435-2435.
FULL TEXT  

Smoking Cessation
Frankenburg
JAMA 2005;294:2434-2434.
FULL TEXT  

Don't Wait for Them to Ask
Beckley
DOC News 2005;2:10-10.
FULL TEXT